Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Brain dopamine receptors: 20 years of progress.

Literature DB >> 8464534

Brain dopamine receptors: 20 years of progress.

Abstract

I present a brief overview of the contributions of Paul Greengard's laboratory to the field of dopamine receptor research. I show that the work on the biochemical pharmacology of dopamine receptors was part of the intellectual foundation for the division of dopamine receptors into two general pharmacological categories.

Entities: Chemical

Mesh：

Substances：
Receptors, Dopamine

Year: 1993 PMID： 8464534 DOI： 10.1007/bf00966928

Source DB: PubMed Journal: Neurochem Res ISSN： 0364-3190 Impact factor: 3.996

30 in total

1. Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys.

Authors: J R Taylor; M S Lawrence; D E Redmond; J D Elsworth; R H Roth; D E Nichols; R B Mailman
Journal: Eur J Pharmacol Date: 1991-07-09 Impact factor: 4.432

2. Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor.

Authors: M Tiberi; K R Jarvie; C Silvia; P Falardeau; J A Gingrich; N Godinot; L Bertrand; T L Yang-Feng; R T Fremeau; M G Caron
Journal: Proc Natl Acad Sci U S A Date: 1991-09-01 Impact factor: 11.205

3. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.

Authors: R K Sunahara; H C Guan; B F O'Dowd; P Seeman; L G Laurier; G Ng; S R George; J Torchia; H H Van Tol; H B Niznik
Journal: Nature Date: 1991-04-18 Impact factor: 49.962

4. D1 and D2 dopamine receptor mRNA in rat brain.

Authors: D M Weiner; A I Levey; R K Sunahara; H B Niznik; B F O'Dowd; P Seeman; M R Brann
Journal: Proc Natl Acad Sci U S A Date: 1991-03-01 Impact factor: 11.205

5. (1R,3S)-1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2-benzopyran: a potent and selective D1 agonist.

Authors: M P DeNinno; R Schoenleber; K E Asin; R MacKenzie; J W Kebabian
Journal: J Med Chem Date: 1990-11 Impact factor: 7.446

6. The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmoset.

Authors: M Nomoto; P Jenner; C D Marsden
Journal: Neurosci Lett Date: 1988-11-11 Impact factor: 3.046

1. Lack of effect of the dopamine D1 antagonist, NNC 01-0687, on unstimulated and stimulated release of anterior pituitary hormones in males.

Authors: E Grodum; M Andersen; J Hangaard; O Koldkjaer; C Hagen
Journal: J Endocrinol Invest Date: 1998-05 Impact factor: 4.256

1 in total

Brain dopamine receptors: 20 years of progress.

1. Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys.

2. Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor.

3. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.

4. D1 and D2 dopamine receptor mRNA in rat brain.

5. (1R,3S)-1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2-benzopyran: a potent and selective D1 agonist.

6. The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmoset.

7. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.

8. Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation.

9. A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets.

10. Human dopamine D1 receptor encoded by an intronless gene on chromosome 5.

1. Lack of effect of the dopamine D1 antagonist, NNC 01-0687, on unstimulated and stimulated release of anterior pituitary hormones in males.